August 15, 2014
The University of Michigan (U-M) ranks #11 in a new list of the most cited researchers, published by Thompson Reuters. Among the U-M scientists determined to be in the top 1% of their field is Angela Fagerlin, Ph.D., part of HSR&D's Center for Clinical Management (CCMR). More than 3,200 researchers worldwide are included in the list, which ranks an individual's impact based on a survey of highly cited papers between 2002 and 2012.
Dr. Fagerlin's training is in cognitive psychology, and her research focus is testing methods for communicating the risks and benefits of treatment to patients (e.g., decision aids). She has developed and tested decision aids for cancer prevention, evaluating whether different design features for the decision aids influence the patient's decision-making process. For example, an HSR&D study led by Dr. Fagerlin compared the impact of a plain language decision aid to a conventional decision aid on prostate cancer patients' decision-making experience and communication with their VA physicians. Another HSR&D study led by Dr. Fagerlin evaluated the effectiveness of methods for communicating the results of genetic testing for risk of colorectal cancer to Veterans. Her other research interests include studying cognitive biases involved in medical decision-making, as well as the use of living wills at the end of life.
Dr. Fagerlin also is co-Director of the Center for Bioethics and Social Sciences in Medicine (CBSSM) in the Medical School at the University of Michigan.